Breaking News Instant updates and real-time market news.

PFSI

PennyMac Financial

$25.40 /

+3.74 (+17.27%)

10:00
03/17/20
03/17
10:00
03/17/20
10:00

PennyMac Financial rises 16.7%

PennyMac Financial is up 16.7%, or $3.64 to $25.40.

PFSI PennyMac Financial
$25.40 /

+3.74 (+17.27%)

02/28/20 Keefe Bruyette
PennyMac Financial upgraded to Outperform from Market Perform at Keefe Bruyette
02/13/20 Wells Fargo
PennyMac selloff on BlackRock sale a buying opportunity, says Wells Fargo
02/10/20 Wedbush
PennyMac Financial price target raised to $40 from $34 at Wedbush
12/08/19 Keefe Bruyette
PennyMac downgraded to Market Perform from Outperform at Keefe Bruyette

TODAY'S FREE FLY STORIES

Upgrade
Novozymes upgraded to Overweight from Underweight at Barclays » 05:17
01/25/21
01/25
05:17
01/25/21
05:17
NVZMY

Novozymes

$0.00 /

+ (+0.00%)

Barclays analyst Cezara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVZMY Novozymes
$0.00 /

+ (+0.00%)

11/19/20 Barclays
Novozymes price target raised to DKK 350 from DKK 340 at Barclays
11/18/20 Barclays
Novozymes price target raised to DKK 350 from DKK 340 at Barclays
10/08/20 Berenberg
Novozymes downgraded to Sell from Hold at Berenberg
10/01/20 Deutsche Bank
Novozymes price target raised to DKK 360 from DKK 320 at Deutsche Bank
Hot Stocks
LexinFintech sees FY21 loan originations RMB 220B-RMB 230B » 05:16
01/25/21
01/25
05:16
01/25/21
05:16
LX

LexinFintech

$6.59 /

-0.02 (-0.30%)

LexinFintech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LX LexinFintech
$6.59 /

-0.02 (-0.30%)

LX LexinFintech
$6.59 /

-0.02 (-0.30%)

06/16/20 China Renaissance
China Renaissance ups LexinFintech to Buy, raises Fintech sector to Overweight
06/15/20 China Renaissance
LexinFintech upgraded to Buy from Hold at China Renaissance
06/09/20 Citi
LexinFintech upgraded to Buy following pullback at Citi
06/09/20 Citi
LexinFintech upgraded to Buy from Neutral at Citi
LX LexinFintech
$6.59 /

-0.02 (-0.30%)

LX LexinFintech
$6.59 /

-0.02 (-0.30%)

LX LexinFintech
$6.59 /

-0.02 (-0.30%)

Upgrade
Leoni upgraded to Neutral from Underweight at JPMorgan » 05:15
01/25/21
01/25
05:15
01/25/21
05:15
LNNNY

Leoni

$0.00 /

+ (+0.00%)

JPMorgan analyst Jose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Outokumpu upgraded to Overweight from Underweight at JPMorgan » 05:13
01/25/21
01/25
05:13
01/25/21
05:13
OUTKY

Outokumpu

$0.00 /

+ (+0.00%)

JPMorgan analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OUTKY Outokumpu
$0.00 /

+ (+0.00%)

01/19/21 Morgan Stanley
Outokumpu price target raised to EUR 3.20 from EUR 2.70 at Morgan Stanley
01/18/21 Exane BNP Paribas
Outokumpu downgraded to Neutral from Outperform at Exane BNP Paribas
12/16/20 SEB Equities
Outokumpu upgraded to Buy from Hold at SEB Equities
12/10/20 Jefferies
Outokumpu downgraded to Underperform from Hold at Jefferies
Hot Stocks
Philips, Vithas Group enter five-year innovation and collaboration agreement » 05:13
01/25/21
01/25
05:13
01/25/21
05:13
PHG

Philips

$55.60 /

+0.22 (+0.40%)

Philips and Vithas Group,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHG Philips
$55.60 /

+0.22 (+0.40%)

PHG Philips
$55.60 /

+0.22 (+0.40%)

01/20/21 Berenberg
Philips price target raised to EUR 50 from EUR 49 at Berenberg
01/19/21 JPMorgan
Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan
11/12/20 Berenberg
Philips price target raised to EUR 49 from EUR 46 at Berenberg
10/29/20 Morgan Stanley
Philips price target raised to EUR 50 from EUR 48 at Morgan Stanley
PHG Philips
$55.60 /

+0.22 (+0.40%)

PHG Philips
$55.60 /

+0.22 (+0.40%)

PHG Philips
$55.60 /

+0.22 (+0.40%)

Downgrade
Ocean Yield downgraded to Hold from Buy at Danske Bank » 05:11
01/25/21
01/25
05:11
01/25/21
05:11
OYIEF

Ocean Yield

$0.00 /

+ (+0.00%)

Danske Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OYIEF Ocean Yield
$0.00 /

+ (+0.00%)

09/08/20 Danske Bank
Ocean Yield upgraded to Buy from Hold at Danske Bank
05/13/20 Pareto
Ocean Yield downgraded to Hold from Buy at Pareto
04/29/20 DNB Markets
Ocean Yield upgraded to Buy from Hold at DNB Markets
03/09/20 DNB Markets
Ocean Yield downgraded to Hold from Buy at DNB Markets
Upgrade
Topdanmark upgraded to Buy from Hold at Danske Bank » 05:10
01/25/21
01/25
05:10
01/25/21
05:10
TPDKY

Topdanmark

$0.00 /

+ (+0.00%)

Danske Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPDKY Topdanmark
$0.00 /

+ (+0.00%)

01/14/21 SEB Equities
Topdanmark upgraded to Buy from Hold at SEB Equities
11/25/20 Danske Bank
Topdanmark downgraded to Hold from Buy at Danske Bank
11/24/20 Barclays
Topdanmark price target raised to DKK 290 from DKK 287 at Barclays
10/27/20 Berenberg
Topdanmark price target lowered to DKK 284 from DKK 290 at Berenberg
Upgrade
CD Projekt upgraded to Buy from Underperform at Jefferies » 05:10
01/25/21
01/25
05:10
01/25/21
05:10
OTGLY

CD Projekt

$0.00 /

+ (+0.00%)

Jefferies analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTGLY CD Projekt
$0.00 /

+ (+0.00%)

OTGLY CD Projekt
$0.00 /

+ (+0.00%)

01/12/21 Berenberg
CD Projekt downgraded to Sell from Hold at Berenberg
12/18/20 Erste Group
CD Projekt downgraded to Reduce from Buy at Erste Group
12/11/20 Barclays
CD Projekt downgraded to Underweight from Equal Weight at Barclays
12/09/20 Jefferies
CD Projekt downgraded to Underperform from Hold at Jefferies
OTGLY CD Projekt
$0.00 /

+ (+0.00%)

OTGLY CD Projekt
$0.00 /

+ (+0.00%)

Recommendations
Apple price target raised to $150 from $140 at Raymond James » 05:07
01/25/21
01/25
05:07
01/25/21
05:07
AAPL

Apple

$138.93 /

+2.04 (+1.49%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$138.93 /

+2.04 (+1.49%)

AAPL Apple
$138.93 /

+2.04 (+1.49%)

01/22/21 Cowen
Apple price target raised to $153 from $133 at Cowen
01/21/21 DA Davidson
Apple's well positioned with first lineup of 5G phones, says DA Davidson
01/21/21 Evercore ISI
Facebook price target raised to $355 from $320 at Evercore ISI
01/21/21 Cowen
Apple EV opportunity may be in partnership, says Cowen
AAPL Apple
$138.93 /

+2.04 (+1.49%)

AAPL Apple
$138.93 /

+2.04 (+1.49%)

AAPL Apple
$138.93 /

+2.04 (+1.49%)

AAPL Apple
$138.93 /

+2.04 (+1.49%)

Hot Stocks
uCloudlink, Vision expand mobile data connectivity partnership » 05:07
01/25/21
01/25
05:07
01/25/21
05:07
UCL

uCloudlink

$10.36 /

+0.11 (+1.07%)

uCloudlink and Vision…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UCL uCloudlink
$10.36 /

+0.11 (+1.07%)

  • 10
    Jun
Upgrade
Dai-ichi Life upgraded to Conviction Buy from Buy at Goldman Sachs » 05:03
01/25/21
01/25
05:03
01/25/21
05:03
DCNSF

Dai-ichi Life

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DCNSF Dai-ichi Life
$0.00 /

+ (+0.00%)

07/01/20 Goldman Sachs
Dai-ichi Life upgraded to Buy from Neutral at Goldman Sachs
06/17/20 Daiwa
Dai-ichi Life upgraded to Buy from Neutral at Daiwa
Recommendations
Novocure price target raised to $225 from $140 at Piper Sandler » 05:01
01/25/21
01/25
05:01
01/25/21
05:01
NVCR

Novocure

$168.99 /

-2.74 (-1.60%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$168.99 /

-2.74 (-1.60%)

NVCR Novocure
$168.99 /

-2.74 (-1.60%)

01/12/21 Wedbush
Novocure price target raised to $159 from $110 at Wedbush
10/30/20 Mizuho
Novocure price target raised to $150 from $84 at Mizuho
10/29/20 Piper Sandler
Novocure price target raised to $140 from $125 at Piper Sandler
10/05/20 Piper Sandler
Bristol-Myers approval removes some Novocure revenue upside, says Piper Sandler
NVCR Novocure
$168.99 /

-2.74 (-1.60%)

Initiation
Cushman & Wakefield initiated with a Neutral at Goldman Sachs » 04:59
01/25/21
01/25
04:59
01/25/21
04:59
CWK

Cushman & Wakefield

$15.19 /

+0.28 (+1.88%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CWK Cushman & Wakefield
$15.19 /

+0.28 (+1.88%)

CWK Cushman & Wakefield
$15.19 /

+0.28 (+1.88%)

12/21/20 JPMorgan
Cushman & Wakefield price target raised to $17 from $13 at JPMorgan
09/17/20
Fly Intel: Top five analyst initiations
09/17/20 Raymond James
Cushman & Wakefield initiated with an Outperform at Raymond James
09/16/20 Raymond James
Cushman & Wakefield initiated with an Outperform at Raymond James
CWK Cushman & Wakefield
$15.19 /

+0.28 (+1.88%)

CWK Cushman & Wakefield
$15.19 /

+0.28 (+1.88%)

CWK Cushman & Wakefield
$15.19 /

+0.28 (+1.88%)

Initiation
Colliers International initiated with a Neutral at Goldman Sachs » 04:58
01/25/21
01/25
04:58
01/25/21
04:58
CIGI

Colliers International

$93.44 /

+0.635 (+0.68%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIGI Colliers International
$93.44 /

+0.635 (+0.68%)

CIGI Colliers International
$93.44 /

+0.635 (+0.68%)

10/28/20 Raymond James
Colliers International price target raised to $90 from $75 at Raymond James
03/10/20 RBC Capital
RBC backs Outperform on Colliers amid economic uncertainty
02/14/20 RBC Capital
Colliers International price target raised to $94 from $80 at RBC Capital
CIGI Colliers International
$93.44 /

+0.635 (+0.68%)

Initiation
Newmark initiated with a Buy at Goldman Sachs » 04:57
01/25/21
01/25
04:57
01/25/21
04:57
NMRK

Newmark

$7.33 /

+0.115 (+1.60%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMRK Newmark
$7.33 /

+0.115 (+1.60%)

NMRK Newmark
$7.33 /

+0.115 (+1.60%)

12/23/20 Piper Sandler
Newmark price target raised to $7.50 from $5 at Piper Sandler
04/09/20 BofA
Newmark double-downgraded to Underperform from Buy at BofA
04/09/20 BofA
Newmark downgraded to Underperform from Buy at BofA
02/14/20 Wedbush
Newmark downgraded to Neutral from Outperform at Wedbush
NMRK Newmark
$7.33 /

+0.115 (+1.60%)

Initiation
Jones Lang LaSalle initiated with a Buy at Goldman Sachs » 04:56
01/25/21
01/25
04:56
01/25/21
04:56
JLL

Jones Lang LaSalle

$159.86 /

+5.25 (+3.40%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$159.86 /

+5.25 (+3.40%)

JLL Jones Lang LaSalle
$159.86 /

+5.25 (+3.40%)

12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform from Outperform at Keefe Bruyette
04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral as 'riskiest' CRE broker at JPMorgan
JLL Jones Lang LaSalle
$159.86 /

+5.25 (+3.40%)

Initiation
CBRE Group initiated with a Buy at Goldman Sachs » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
CBRE

CBRE Group

$65.99 /

+0.96 (+1.48%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBRE CBRE Group
$65.99 /

+0.96 (+1.48%)

CBRE CBRE Group
$65.99 /

+0.96 (+1.48%)

12/21/20 JPMorgan
CBRE Group price target raised to $65 from $52 at JPMorgan
04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral as 'riskiest' CRE broker at JPMorgan
04/09/20 JPMorgan
CBRE Group downgraded to Neutral on valuation at JPMorgan
04/09/20 JPMorgan
CBRE Group downgraded to Neutral from Overweight at JPMorgan
CBRE CBRE Group
$65.99 /

+0.96 (+1.48%)

Conference/Events
Stephens specialty finance analyst to hold analyst/industry conference call » 04:55
01/25/21
01/25
04:55
01/25/21
04:55

Specialty Finance Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
FedEx management to meet virtually with Oppenheimer » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
FDX

FedEx

$254.00 /

+0.06 (+0.02%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

01/07/21 Wolfe Research
FedEx downgraded to Peer Perform from Outperform at Wolfe Research
12/30/20 Argus
FedEx price target raised to $305 from $270 at Argus
12/18/20 Raymond James
FedEx price target raised to $305 from $280 at Raymond James
12/18/20 Morgan Stanley
FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley
FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

General news
6-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
General news
3-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
General news
3-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
Conference/Events
Seelos Therapeutics management to meet virtually with Roth Capital » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
SEEL

Seelos Therapeutics

$2.58 /

+0.47 (+22.27%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEEL Seelos Therapeutics
$2.58 /

+0.47 (+22.27%)

SEEL Seelos Therapeutics
$2.58 /

+0.47 (+22.27%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
  • 12
    Mar
  • 11
    Feb
Conference/Events
Navidea management to meet virtually with Oppenheimer » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
NAVB

Navidea

$2.27 /

+0.025 (+1.12%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAVB Navidea
$2.27 /

+0.025 (+1.12%)

NAVB Navidea
$2.27 /

+0.025 (+1.12%)

08/17/20 H.C. Wainwright
Navidea price target raised to $8 from $6 at H.C. Wainwright
05/22/20 H.C. Wainwright
Navidea price target raised to $6 from $4 at H.C. Wainwright
NAVB Navidea
$2.27 /

+0.025 (+1.12%)

NAVB Navidea
$2.27 /

+0.025 (+1.12%)

Conference/Events
Newborn Acquisition Corp. management to meet virtually with Roth Capital » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
NBAC

Newborn Acquisition Corp.

$17.65 /

-0.29 (-1.62%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBAC Newborn Acquisition Corp.
$17.65 /

-0.29 (-1.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.